215 related articles for article (PubMed ID: 33960307)
1. Circulating miR-660-5p is associated with no-reflow phenomenon in patients with ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Zhang J; He L
Anatol J Cardiol; 2021 May; 25(5):323-329. PubMed ID: 33960307
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D level predicts angiographic no-reflow phenomenon after percutaneous coronary intervention in patients with ST segment elevation myocardial infarction.
Şen Ö; Şen SB; Topuz AN; Topuz M
Biomark Med; 2021 Oct; 15(15):1357-1366. PubMed ID: 34533051
[No Abstract] [Full Text] [Related]
3. Elevated uric acid is related to the no-/slow-reflow phenomenon in STEMI undergoing primary PCI.
Hu X; Yang X; Li X; Li G; Zhou Y; Dong H
Eur J Clin Invest; 2022 Apr; 52(4):e13719. PubMed ID: 34800289
[TBL] [Abstract][Full Text] [Related]
4. New CHA
Zhang QY; Ma SM; Sun JY
BMC Cardiovasc Disord; 2020 Jul; 20(1):346. PubMed ID: 32711475
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of fibrinogen-to-albumin ratio to predict no-reflow and short-term prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Zhao Y; Yang J; Ji Y; Wang S; Wang T; Wang F; Tang J
Heart Vessels; 2019 Oct; 34(10):1600-1607. PubMed ID: 30993442
[TBL] [Abstract][Full Text] [Related]
6. Serum Endocan Levels Predict Angiographic No-Reflow Phenomenon in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Coronary Intervention.
Dogdus M; Yenercag M; Ozyasar M; Yilmaz A; Can LH; Kultursay H
Angiology; 2021 Mar; 72(3):221-227. PubMed ID: 32996338
[TBL] [Abstract][Full Text] [Related]
7. Impact of platelet inhibition level on subsequent no-reflow in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Aitmokhtar O; Paganelli F; Benamara S; Azaza A; Bonello L; Hamza O; Seddiki S; Benathmane T; Saidane M; Bouzid A; Kara M; Sik A; Azzouz A; Harbi F; Monsuez JJ; Benkhedda S
Arch Cardiovasc Dis; 2017 Nov; 110(11):626-633. PubMed ID: 28583820
[TBL] [Abstract][Full Text] [Related]
8. MELD-XI score predict no-reflow phenomenon and short-term mortality in patient with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Zhang XT; Lin ZR; Zhang L; Zhao ZW; Chen LL
BMC Cardiovasc Disord; 2022 Mar; 22(1):113. PubMed ID: 35300593
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of Mean Platelet Volume-to-Lymphocyte Ratio for Predicting Angiographic No-Reflow and Short-Term Prognosis After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction.
Kurtul A; Acikgoz SK
Am J Cardiol; 2017 Aug; 120(4):534-541. PubMed ID: 28633762
[TBL] [Abstract][Full Text] [Related]
10. Predictors of No-Reflow Phenomenon in Young Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Celik T; Balta S; Ozturk C; Kaya MG; Aparci M; Yildirim OA; Demir M; Unlu M; Demirkol S; Kilic S; Iyisoy A
Angiology; 2016 Aug; 67(7):683-9. PubMed ID: 26369341
[TBL] [Abstract][Full Text] [Related]
11. Relationship between circulating miRNA-30e and no-reflow phenomenon in STEMI patients undergoing primary coronary intervention.
Su Q; Ye Z; Sun Y; Yang H; Li L
Scand J Clin Lab Invest; 2018 Jul; 78(4):318-324. PubMed ID: 29703083
[TBL] [Abstract][Full Text] [Related]
12. Association of monocyte count on admission with angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
Wang Z; Ren L; Liu N; Lei L; Ye H; Peng J
Kardiol Pol; 2016; 74(10):1160-1166. PubMed ID: 27160177
[TBL] [Abstract][Full Text] [Related]
13. The relationship between serum rheumatoid factor level and no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Quisi A; Alıcı G
J Clin Lab Anal; 2018 Nov; 32(9):e22598. PubMed ID: 29943408
[TBL] [Abstract][Full Text] [Related]
14. SYNTAX score is a predictor of angiographic no-reflow in patients with ST-elevation myocardial infarction treated with a primary percutaneous coronary intervention.
Şahin DY; Gür M; Elbasan Z; Kuloğlu O; Şeker T; Kivrak A; Tanboğa İH; Gözübüyük G; Kirim S; Çayli M
Coron Artery Dis; 2013 Mar; 24(2):148-53. PubMed ID: 23363986
[TBL] [Abstract][Full Text] [Related]
15. The relation between monocyte to HDL ratio and no-reflow phenomenon in the patients with acute ST-segment elevation myocardial infarction.
Balta S; Celik T; Ozturk C; Kaya MG; Aparci M; Yildirim AO; Demir M; Kilic S; Aydin İ; Iyisoy A
Am J Emerg Med; 2016 Aug; 34(8):1542-7. PubMed ID: 27238848
[TBL] [Abstract][Full Text] [Related]
16. Systemic immune-inflammation index predicts no-reflow phenomenon after primary percutaneous coronary intervention.
Esenboğa K; Kurtul A; Yamantürk YY; Tan TS; Tutar DE
Acta Cardiol; 2022 Feb; 77(1):59-65. PubMed ID: 33612077
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of the platelet-to-lymphocyte ratio in predicting angiographic reflow after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.
Kurtul A; Yarlioglues M; Murat SN; Ergun G; Duran M; Kasapkara HA; Demircelik MB; Cetin M; Ocek AH
Am J Cardiol; 2014 Aug; 114(3):342-7. PubMed ID: 24948493
[TBL] [Abstract][Full Text] [Related]
18. Plasma apelin-12 levels may predict in-hospital major adverse cardiac events in ST-elevation myocardial infarction and the relationship between apelin-12 and the neutrophil/lymphocyte ratio in patients undergoing primary coronary intervention.
Topuz M; Oz F; Akkus O; Sen O; Topuz AN; Bulut A; Ozbicer S; Okar S; Koc M; Gur M
Perfusion; 2017 Apr; 32(3):206-213. PubMed ID: 27770057
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of monocyte chemoattractant protein-1 to predict no-reflow and three-year mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Buyukkaya E; Poyraz F; Karakas MF; Kurt M; Akcay AB; Akpinar I; Motor S; Turak O; Ozturk OH; Sen N; Akpek M; Kaya MG; Gibson CM
Am J Cardiol; 2013 Jul; 112(2):187-93. PubMed ID: 23601576
[TBL] [Abstract][Full Text] [Related]
20. Predictors of no-reflow phenomenon following percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Aggarwal P; Rekwal L; Sinha SK; Nath RK; Khanra D; Singh AP
Ann Cardiol Angeiol (Paris); 2021 Jun; 70(3):136-142. PubMed ID: 33962782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
